Suzuken News

Suzuken: Notice regarding organizational changes, executive personnel personnel, executive officer personnel, and personnel changes at subsidiaries

Feb 12 01:00 ET

Suzuken: Notice regarding organizational restructuring, executive personnel personnel, executive officer personnel, director personnel, and personnel changes

Feb 12 01:00 ET

Suzuken: Decision on the grant of the Reiwa 6 Research Grants for the Kenzo Suzuki Memorial Medical Science Applied Research Foundation

Nov 26, 2024 00:00 ET

Suzuken: Notice regarding the relocation of the Saga Sales Division Karatsu Branch

Nov 11, 2024 00:00 ET

Suzuken: Notice regarding executive personnel affairs at subsidiary companies

Oct 25, 2024 01:00 ET

Suzuken: Notice regarding personnel changes at subsidiaries

Oct 1, 2024 01:00 ET

Suzuken: Notice regarding executive officer personnel and personnel changes

Sep 27, 2024 01:00 ET

Suzuken: Announcement of the start of in-home delivery service for the drug “Vesulemi Dermal Injection 250 μg Syringe/500 μg Syringe” for the treatment of polycythemia vera by Pharma Essencia Japan Co., Ltd.

Sep 25, 2024 01:00 ET

Suzuken: Suzuken Group and Cancer Research Group Begin Joint Research on Evaluation of Cancer Medication Adherence at Akira Hospital - Utilizing the Newly Developed Medication Management System “CubiXXDT (Japan Version)”

Sep 25, 2024 01:00 ET

Suzuken: Notice regarding integration of Wakayama Sales Division Kihoku Branch and relocation of Chiba Sales Department Matsudo Branch

Sep 25, 2024 01:00 ET

Suzuken: Notice Concerning the Recording of Extraordinary Profit (Gains on Sale of Investment Securities)

Aug 30, 2024 02:00 ET

Suzuken: Independent Officer Notification Form

May 31, 2024 02:00 ET

Suzuken: Notice regarding the integration of Suzuken Iwate Miyako Branch

May 23, 2024 01:00 ET

Suzuken: Suzuken, FRONTEO, and Shionogi Pharmaceutical aim for social implementation of an AI program to support conversational dementia diagnosis through collaboration between 3 companies

May 13, 2024 04:00 ET

Suzuken: Suzuken Group, EPS Holdings, and Bushu Pharmaceutical sign partnership agreement to support entry of unapproved domestic drugs (drug loss items) into the Japanese market

May 9, 2024 01:00 ET

Suzuken: Notice regarding joint development and dissemination of new healthcare services by Suzuken, Chubu Electric Power Company, and Welby

Apr 10, 2024 02:30 ET

Suzuken: Notice regarding the integration of the Ehime Sales Department Ozu Branch

Mar 25, 2024 01:00 ET

Suzuken: Notice regarding the operation of a distribution center in the Tokyo metropolitan area - the industry's first complex logistics center with a manufacturing contract and manufacturer logistics area attached to the wholesale logistics base-

Mar 12, 2024 22:00 ET

Suzuken: Seven Suzuken Group Corporations Selected as “Excellent Health Management Corporations 2024”

Mar 11, 2024 02:00 ET

Suzuken: Notice regarding personnel affairs of directors at subsidiary companies

Feb 28, 2024 00:00 ET